Drug Profile


Alternative Names: HN 770; HSR 770; HY 770; Inaperisone hydrochloride; Riran; YM 170

Latest Information Update: 22 Dec 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hokuriku Seiyaku
  • Developer Hokuriku Seiyaku; Yamanouchi
  • Class Propiophenones; Small molecules
  • Mechanism of Action Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Muscle hypertonia; Urinary incontinence

Most Recent Events

  • 22 Dec 1999 Discontinued-preregistration for Urinary incontinence in Japan (PO)
  • 20 May 1998 Discontinued-preregistration for Hypertonia in Japan (PO)
  • 02 Feb 1998 No-Development-Reported for Hypertonia in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top